RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. UPMC Enterprises
U

UPMC Enterprises portfolio

UPMC Enterprises has 10 portfolio companies on record at Recent Funding, with 4 investments in the last 12 months.

Website: upmc.com.
Type: Corporate venture.
Portfolio on Recent Funding: 10.
Deals, last 12 months: 4.
Rounds led: 2 of 9.
Capital in their rounds: $562.5M.
Latest deal: Estuary Biotherapeutics · Oct 16, 2026.
About this page

It is a corporate venture investor based in Pittsburgh, US. It led 2 of the 9 rounds it joined. Its most recent investment on record is Estuary Biotherapeutics's $103M Series A round in October 2026, alongside 4BIO Capital, Deep Track Capital, Biogen New Ventures and 4 others. By category, its portfolio leans toward Health and bio (10) and Consumer and social (2). It has co-invested with GV, S3 Ventures and Next Coast Ventures, most often GV (2 rounds).

About UPMC Enterprises

Firm type: Corporate venture.
Headquarters: Pittsburgh, US.
Stages: Seed, Growth.
Sectors: Biotech, Digital Health, Healthtech.
Portfolio companies: 11.
Exits: 0.
Rounds led: 6.

What UPMC Enterprises invests in

UPMC Enterprises recent investments

CompanyRoundDateAlongside
EEstuary BiotherapeuticsSeries A · $103M4BIO Capital, Deep Track Capital, Biogen New Ventures +4
Aai3BioSeries A · $48M · leadTanis ventures, Cockrell Interests, ZiffCap (lead)
BBrainCheckSeries A · $13MNext Coast Ventures (lead), S3 Ventures
PPrecedeSeries B+ · $83.5MIllumina Ventures, Lilly Asia Ventures, OUP +6
UUltromicsSeries B+ · $55MLegal & General (lead), UCM Ventures, Lightrock (lead) +5
CCarta HealthcareSeries B+ · $18M · leadStorm Ventures, Memorial Hermann Health System, Paramark Ventures +6
OOuro MedicinesSeries A · $120MMonograph Capital, NEA (lead), TPG (lead) +4
NNoema PharmaSeries B+ · $112MGilde Healthcare, Forbion Capital Partners (lead), Invus +3

How UPMC Enterprises invests

StageDealsCapital in rounds
Series B+ 5 56%$278.5M
Series A 4 44%$284M
YearDealsCapital in rounds
2021 1 11%$10M
2023 1 11%$112M
2025 3 33%$193M
2026 4 44%$247.5M

UPMC Enterprises portfolio companies

CompanyRound with UPMC EnterprisesTotal raisedLatest raise
EEstuary Biotherapeutics
Health and bio
Series A · $103M$103MOct 16, 2026
Series A
Aai3Bio
Health and bio
Series A · $48M · lead$48MSep 29, 2026
Series A
BBrainCheck
Health and bio
Series A · $13M$37MFeb 27, 2026
Series A
PPrecede
Health and bio
Series B+ · $83.5M$83.5MJan 12, 2026
Series B+
UUltromics
Health and bio
Series B+ · $55M$111MAug 11, 2025
Series B+
CCarta Healthcare
Health and bio
Series B+ · $18M · lead$80MJun 7, 2025
Series B+
OOuro Medicines
Health and bio
Series A · $120M$120MJan 10, 2025
Series A
NNoema Pharma
Health and bio
Series B+ · $112M$171MNov 4, 2025
Series B+
PPercipio
Health and bio
backer$16MDec 26, 2025
Series A
KKoda Health
Health and bio
backer$10.5MOct 2, 2025
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 9 rounds on Recent Funding that name UPMC Enterprises. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists UPMC Enterprises, which is a subset of its real portfolio. API: /api/v1/investors/upmc-enterprises (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy